Brief: Unicycive Therapeutics Inc - On February 1, 2023, Nasdaq Notified The Company That It Had Not Regained Compliance With The Minimum Bid Price Rule
30/03/2023 11:30
March 30 (Reuters) - Unicycive Therapeutics Inc
UNCY.O :
* UNICYCIVE THERAPEUTICS INC - ON FEBRUARY 1, 2023, NASDAQ
NOTIFIED THE COMPANY THAT IT HAD NOT REGAINED COMPLIANCE WITH
THE MINIMUM BID PRICE RULE
* UNICYCIVE THERAPEUTICS INC - ON MARCH 28, CO RECEIVED
NOTICE
FROM NASDAQ THAT HAS REGAINED COMPLIANCE WITH THE MINIMUM BID
PRICE REQUIREMENT
Further company coverage: UNCY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unicycive Therapeutics
See all newsBrief: Unicycive Therapeutics Appoints Meredith Manning To Board Of Directors
Brief: Unicycive Therapeutics Announces Resubmission Of New Drug Application For Oxylanthanum Carbonate
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
Unicycive rises on narrower quarterly loss